- Home
- POAI vs YCBD Comparison
POAI vs YCBD Comparison
Compare POAI & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- YCBD
- Stock Information
- Founded
- POAI 2002
- YCBD 2015
- Country
- POAI United States
- YCBD United States
- Employees
- POAI N/A
- YCBD N/A
- Industry
- POAI Industrial Specialties
- YCBD Biotechnology: Pharmaceutical Preparations
- Sector
- POAI Health Care
- YCBD Health Care
- Exchange
- POAI Nasdaq
- YCBD Nasdaq
- Market Cap
- POAI 7.8M
- YCBD 7.8M
- IPO Year
- POAI N/A
- YCBD N/A
- Fundamental
- Price
- POAI $0.93
- YCBD $0.70
- Analyst Decision
- POAI Hold
- YCBD Strong Buy
- Analyst Count
- POAI 1
- YCBD 1
- Target Price
- POAI N/A
- YCBD $2.00
- AVG Volume (30 Days)
- POAI 122.8K
- YCBD 103.3K
- Earning Date
- POAI 11-11-2025
- YCBD 08-14-2025
- Dividend Yield
- POAI N/A
- YCBD N/A
- EPS Growth
- POAI N/A
- YCBD N/A
- EPS
- POAI N/A
- YCBD N/A
- Revenue
- POAI $1,664,696.00
- YCBD $19,026,064.00
- Revenue This Year
- POAI $486.27
- YCBD $0.37
- Revenue Next Year
- POAI $65.50
- YCBD $4.95
- P/E Ratio
- POAI N/A
- YCBD N/A
- Revenue Growth
- POAI 71.65
- YCBD N/A
- 52 Week Low
- POAI $0.55
- YCBD $0.59
- 52 Week High
- POAI $3.06
- YCBD $6.54
- Technical
- Relative Strength Index (RSI)
- POAI 55.05
- YCBD 43.32
- Support Level
- POAI $0.90
- YCBD $0.68
- Resistance Level
- POAI $1.08
- YCBD $0.73
- Average True Range (ATR)
- POAI 0.07
- YCBD 0.05
- MACD
- POAI 0.00
- YCBD 0.00
- Stochastic Oscillator
- POAI 36.09
- YCBD 23.62
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
About YCBD cbdMD Inc.
cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.